Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Recommended Webinars & Conferences
International Conference on Biotechnology and Healthcare
Auckland, New ZealandBioartificial Liver
Bioartificial liver (BAL) systems are designed to assist malfunctioning livers in patients with various liver diseases. Such systems are composed of a bioreactor device together with functional hepatocytes. It is expected that almost all liver functions, except for the secretion of bile, would be compensated for by BAL systems. Historically, a variety of cells have been studied as sources for the embedded hepatocytes in BAL applications. For example, primary human hepatocytes, immortalized cell lines of C3A human hepatoblastoma cells, liver progenitor cell line HepaRG and cryopreserved porcine hepatocytes have been researched. Some of them have even been explored in clinical investigations.
OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals with the support of 50,000+ editorial board members as editorial team and aimed to disseminate the scholarly knowledge to the scientific society.
- Share this page
Last date updated on November, 2020